LifeStance Health Group, Inc. Reports Third Quarter 2026 Financial Results and Raises Full-Year Outlook

LifeStance Health Group reported third-quarter 2026 revenue of $455.9 million, up 25% year over year, net income of $22.4 million, and Adjusted EBITDA of $68.4 million, up 70%. Growth reflected higher visit volumes, improved clinician productivity, and an 11% increase in its clinician base to 8,863. The company raised its 2026 revenue outlook to $1.741 billion–$1.761 billion and Adjusted EBITDA guidance to $242 million–$250 million, citing platform investments including a new electronic health record system as support for future scale.